Feedback

Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca 2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties

Affiliation
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France;(I.P.-A.);(P.J.B.)
Pachón-Angona, Irene;
Affiliation
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France;(I.P.-A.);(P.J.B.)
Bernard, Paul J.;
ORCID
0000-0002-3076-0030
Affiliation
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France;(A.S.);(H.M.)
Simakov, Alexey;
Affiliation
Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland;(M.M.);(K.J.)
Maj, Maciej;
ORCID
0000-0001-6018-5092
Affiliation
Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland;(M.M.);(K.J.)
Jozwiak, Krzysztof;
Affiliation
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany;(A.N.);(C.L.);(M.G.)
Novotna, Anna;
Affiliation
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany;(A.N.);(C.L.);(M.G.)
Lemke, Carina;
ORCID
0000-0002-9376-7897
Affiliation
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany;(A.N.);(C.L.);(M.G.)
Gütschow, Michael;
ORCID
0000-0001-8318-3858
Affiliation
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France;(A.S.);(H.M.)
Martin, Helene;
ORCID
0000-0002-7223-0222
Affiliation
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain;
Oset-Gasque, María-Jesús;
Affiliation
Laboratory of Medicinal Chemistry (IQOG, CSIC) C/Juan de la Cierva 3, 28006 Madrid, Spain
Contelles, José-Marco;
ORCID
0000-0002-6013-3150
Affiliation
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France;(I.P.-A.);(P.J.B.)
Ismaili, Lhassane

This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a – l , via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2024 by the authors.

Use and reproduction: